Image - Barts and The London logo and link to home page Image - divider Image - divider
  Image - Wolfson Institute of Preventive Medicine title and link to Institute home page
Images - preventive medicine, people
  Image - Centre for Environmental and Preventive Medicine title and link to Centre homepage
Centre for Environmental and Preventive Medicine: publications 1999
Alberman E, Noble JM. Commentary: Food should be fortified with folic acid. BMJ 1999;319:93.
Berkenstadt H, Rosenthal T, Peleg, E, Segal E, Hackshaw A, Ben-Ari G, Perel A. Elevated plasma atrial natriuretic peptide levels after occlusion of the thoracic aorta. Chest 1999;115:130-134.
Bestall J, Paul EA, Garrod R, Garnham R, Jones PW, Wedizcha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-586.
Bridgman CM, Ashby D, Holloway PJ. An investigation of the effects on children of tooth extraction under general anaesthesia in general dental practice. Br Dent J 1999;186:245-247.
Botting B, Skjaerven R, Alberman E, Abrahams C. Multiple congenital anomalies in England and Wales 1992-97. Health Statistics Quarterly 1999;3:24-29.
Dickinson CJ. Mouth bacteria as the cause of Paget's disease of bone. Med Hypotheses 1999;52:209-212.
Dickinson CJ. Could tight garments cause endometriosis? Brit J Obstet Gynaecol 1999;106:1003-1005.
Dormandy E. Antenatal screening. Better understanding of factors influencing uptake is needed. BMJ 1999;318:805.
Edgar DF, Crabb DP, Rudnicka AR, Lawrenson JG, Guttridge NM, O'Brien C. Effects of dipivefrin and pilocarpine on pupil diameter, automated perimetry and logMAR acuity. Graefe's Arch Clin Exp Ophthalmol 1999;237:117-124.
Eldridge S, Cryer C, Feder G, Underwood M. Sample size calculations for community intervention studies randomising complete clusters within Primary Care Groups: an empirical illustration from one proposed intervention study. Abstract. Workshop on Cluster Randomised Trials, Sheffield July 1999.
Feder G, Griffiths C, Eldridge S, Spence M. The effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): a randomised controlled trial. BMJ 1999;318:1522-1526.
Hackshaw A, Wald N, Ayme S. Statement from Panel on Antenatal Screening for Down syndrome. In: Down Syndrome Screening Policy and Economic Evaluations. Beazoglou T, Benn P, Cuckle H, Haddow J, Kyriopoulos J (eds). Exandus, Athens, 1999, 261-265. ISBN: 960-256-370-2.
Harris R & members of CEGEN Steering Committee including Alberman E, Wald N. Clinical governance and genetic medicine. Specialist genetic centres and the Confidential Enquiry into Counselling for Genetic Disorders by non-geneticists (CEGEN). J Med Genet 1999;36:350-351.
Harris R, Lane B, Harris H, Williamson P, Dodge J, Modell B, Ponder B, Rodeck C, Alberman E. National Confidential Enquiry into counselling for genetic disorders by non-geneticists: general recommendations and specific standards for improving care. Br J Obstet Gynaecol 1999;106:658-663.
Hook EB, Cross PK, Mutton DE. Female predominance (low sex ratio) in 47,+21 mosaics. Am J Med Genet 1999;84:316-319. ISSN: 01487299.
Huttly WJ, Wald NH, Walters JC. Folic acid supplementation before pregnancy remains inadequate. BMJ 1999;319:1499.
Law MR. Lowering heart disease risk with cholesterol reduction: evidence from observational studies and clinical trials. Eur Heart J Supplements 1999;1(S):S3-S8.
Law MR, Morris JK. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease: Response to commentary. Eur J Clin Nutr 1999;53:903-904.
Law MR, Morris JK, Wald NJ. The importance of age in screening for cancer. J Med Screen 1999;6:16-20
Law M, Wald N. Why heart disease mortality is low in France: the time lag explanation. BMJ 1999;318:1471-1476, 1479-1480.
Law M, Wald N. Attribution of time lag theory to explain French paradox. BMJ 1999;319:1073.
Law MR, Wald NJ. Homocysteine and ischaemic heart disease. Haematologica 1999;84:57-60.
Mathews F, Murphy M, Wald NJ, Hackshaw A. Twinning and folic acid use. Lancet 1999;353:291-292.
Morris JK, Wald NJ. Quantifying the decline in the birth prevalence of neural tube defects in England and Wales. J Med Screen 1999;6:182-185.
Morris JK, Wald NJ, Watt, HC. Fetal loss in Down syndrome pregnancies. Prenat Diagn 1999;19:142-145.
Prospective Studies Collaboration Group (Wald NJ, Morris JK). Collaborative overview ('meta-analysis') of prospective observational studies of the associations of usual blood pressure and usual cholesterol levels with common causes of death: protocol for the second cycle of the Prospective Studies Collaboration. J Cardiovasc Risk 1999;6:315-320.
Poustie VJ, Watling RM, Ashby D, Smyth RL. Taste preference for oral calorie supplements in children with cystic fibrosis, healthy children and healthy adults. J Hum Nutr Diet 1999;12:301-306.
The Royal College of Physicians Committee on Ethical Issues in Medicine (Wald NJ is member). Research based on archived information and samples. J R Coll Physicians Lond 1999;33:264-266.
Thomson JA, Pilotti V, Stevens P, Ayres KL, Debenham PG. Validation of short tandem repeat analysis for the investigation of cases of disputed paternity. Forensic Sci Int 1999;100:1-16.
Wald NJ, Dormandy EF. Reporting of screening results. J Med Screen 1999;6:117-118.
Wald NJ, Hackshaw AK. Development and implementation of Down's syndrome screening. In: Down Syndrome Screening Policy and Economic Evaluations. Beazoglou T, Benn P, Cuckle H, Haddow J, Kyriopoulos J (eds). Exandus, Athens, 1999, 43-54. ISBN: 960-256-370-2.
Wald NJ, Hackshaw AK, Diamandis EP, Melegos DN. Maternal serum prostate-specific antigen and Down syndrome in the first and second trimesters of pregnancy. Prenat Diagn 1999;19:674-676.
Wald NJ, Hackshaw AK, Frost CD. When can a risk factor be used as a worthwhile screening test? BMJ 1999;319:1562-1565.
Wald NJ, Hackshaw, Watt H. Nuchal translucency and trisomy 18. Prenat Diagn 1999;19:995-996.
Wald NJ, Huttly WJ. Validation of risk estimation using the quadruple test in prenatal screening. Prenat Diagn 1999;19:1083-1084.
Wald NJ, Huttly WJ, Hennessy CF. Down's syndrome screening in the UK in 1998. Lancet 1999;354:1264.
Wald NJ, Noble J. Primary prevention of neural tube defects. In: Fetal Medicine: Basic Science and Clinical Practice. Rodeck CH, Whittle MJ (eds). London, Churchill Livingstone, 1999, 283-290. ISBN: 0-4430-5357X
Wald NJ, Watt HC. The target plot: a new way of displaying the performance of a screening test. J Med Screen 1999;6:195-199.
Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999;341:461-467.
Wald NJ, Watt HC, Norgaard-Pedersen B, Christiansen M. SP1 in pregnancies with Down syndrome in the first trimester of pregnancy. Prenat Diagn 1999;19:517-520.
Wald NJ, White N, Morris JK, Huttly WJ, Canick JA. Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening. Br J Obstet Gynaecol 1999;106:1304-1306
Walton J, (Lord Walton of Detchant), Doll R, Asscher W, Hurley R, Langman M, Gillon R, Strachan D, Wald N, Fletcher P. Consequences for research if use of anonymised patient data breaches confidentiality. BMJ 1999;319:1366. ISSN: 09598138.
Watt HC, Wald NJ, Huttly WJ. Inhibin-A regression. Prenat Diagn 1999;19:893-894.

Useful links:
  WIPM publications hub

by Wolfson Institute Website Manager © Queen Mary, University of London 2011
Centre for Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Barts and The London, Charterhouse Square, London EC1M 6BQ Tel: 020 7882 3850 Fax: 020 7882 6270